Zobrazeno 1 - 10
of 1 219
pro vyhledávání: '"M. Del Tacca"'
Autor:
P. Patrignani, G. Leardini, C. Klersy, M. Del Tacca, O. Della Casa, M.A. Cimmino, B. Canesi, S. Adami, D. Gatti, L. Punzi, S. Bombardieri
Publikováno v:
Reumatismo, Vol 58, Iss 2, Pp 85-93 (2011)
Fin dalla loro scoperta, circa 40 anni fa, i farmaci antinfiammatori non steroidei (FANS) hanno rappresentato una delle classi di farmaci più utilizzate. Grazie a loro è radicalmente migliorata la capacità di controllare flogosi e dolore sia acuti
Externí odkaz:
https://doaj.org/article/f6caaa0b2ee44045ba0bbddd4c839920
Publikováno v:
European Journal of Histochemistry, Vol 47, Iss 4 (2009)
Transforming growth factor-a (TGF-a) plays an important role in both proliferation and differentiation of mucosal cells at the gastrointestinal level, including stomach, where it is constitutively produced. This study evaluated the immunohistochemica
Externí odkaz:
https://doaj.org/article/3f8d94f42594459fa24d14fde5635153
Autor:
Guido Bocci, A. Paradiso, Anita Mangia, Sinto Sebastian, Ae Quatrale, Letizia Porcelli, M. Del Tacca, Gm Simone, Donatella Del Bufalo, Patrizia Chiarappa, P Sini, Anna Fioravanti, Amalia Azzariti
Publikováno v:
British Journal of Cancer
Background: AZD1152, the prodrug for AZD1152-hydroxyquinazoline pyrazol anilide (HQPA), is a selective inhibitor of Aurora B kinase activity. Preclinical evaluation of AZD1152 has been reported in several human cancer models. The potentiality of this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b57b15b72daa3bb5a269be0ca12be12
https://doi.org/10.1038/bjc.2011.21
https://doi.org/10.1038/bjc.2011.21
Autor:
Guido Bocci, Alfredo Falcone, Lorenzo Fornaro, M. Del Tacca, Romano Danesi, Chiara Cremolini, Gianluca Masi, Giuseppe Pasqualetti, Lisa Salvatore, Fotios Loupakis
Publikováno v:
Current Cancer Drug Targets. 999:1-9
Targeting vascular endothelial growth factor (VEGF) pathway represents a successful strategy in the treatment of metastatic colorectal cancer (mCRC). Since the approval of the first antiangiogenic drug, the anti-VEGF monoclonal antibody bevacizumab,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97576d41027b258d44695ab09c1c1298
https://doi.org/10.2174/1568210200887950096
https://doi.org/10.2174/1568210200887950096
Autor:
Contreras-Martínez, Orfa Inés1 (AUTHOR) oicontreras@correo.unicordoba.edu.co, Angulo-Ortíz, Alberto2 (AUTHOR) aaangulo@correo.unicordoba.edu.co, Santafé Patiño, Gilmar2 (AUTHOR), Sierra Martinez, Jesus3 (AUTHOR) jesussierra@estudante.ufscar.br, Berrio Soto, Ricardo1 (AUTHOR) rberriosoto54@correo.unicordoba.edu.co, de Almeida Rodolpho, Joice Margareth4 (AUTHOR) j_jrodolpho@hotmail.com, de Godoy, Krissia Franco4 (AUTHOR) krissia.fgodoy@gmail.com, de Freitas Aníbal, Fernanda4 (AUTHOR) ffanibal@ufscar.br, de Lima Fragelli, Bruna Dias5 (AUTHOR) brufragelli@gmail.com
Publikováno v:
Molecules. Sep2024, Vol. 29 Issue 18, p4417. 16p.
Autor:
Andrade-Pavón, Dulce1,2 (AUTHOR) dandradep@ipn.mx, Gómez-García, Omar3 (AUTHOR) dandradep@ipn.mx, Villa-Tanaca, Lourdes1 (AUTHOR)
Publikováno v:
Journal of Fungi. Sep2024, Vol. 10 Issue 9, p629. 35p.
Publikováno v:
British Journal of Pharmacology. 155:198-209
Background and purpose: Cyclooxygenase-2 (COX-2) is expressed in colonic neoplasms, where it supports cell proliferation via prostaglandin E2 (PGE2) production. This study investigated the effects of somatostatin-14 on COX-2 expression, PGE2 producti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1fb152c55b88a458b4d16f246f2353ff
https://doi.org/10.1038/bjp.2008.268
https://doi.org/10.1038/bjp.2008.268
Autor:
Giovanni Barbara, G. Di Nardo, M. Del Tacca, Vincenzo Stanghellini, R Colucci, Marcello Tonini, Umberto Volta, Roberto Corinaldesi, Corrado Blandizzi, R. De Giorgio
Publikováno v:
Alimentary Pharmacology & Therapeutics. 28:25-42
Summary Background Considerable information has been gathered on the functional organization of enteric neuronal circuitries regulating gastrointestinal motility. However, little is known about the neuropathophysiological mechanisms underlying gastro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85d6066c497f95af0b7babd3280768bf
https://doi.org/10.1111/j.1365-2036.2008.03707.x
https://doi.org/10.1111/j.1365-2036.2008.03707.x
Autor:
A. Di Paolo, Antonio Giuseppe Naccarato, Giacomo Allegrini, M. Del Tacca, Romano Danesi, Paola Orlandi, Alfredo Falcone, Anna Fioravanti, Giuseppe Nicolò Fanelli, Paolo Viacava, Guido Bocci, Robert S. Kerbel
Publikováno v:
British Journal of Cancer
Metronomic chemotherapy refers to the administration of chemotherapy at low, nontoxic doses on a frequent schedule with no prolonged breaks. The aim of the study is to rationally develop a CPT-11 metronomic regimen in preclinical settings of colon ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34793c72bdc07355e202462ae20a43a1
http://europepmc.org/articles/PMC2391121
http://europepmc.org/articles/PMC2391121
Autor:
Luca Antonioli, Narcisa Ghisu, M. Del Tacca, Massimo Chiarugi, Rocchina Colucci, Fabio Baschiera, Marco Tuccori, Francesca Crema, Corrado Blandizzi, Piero Buccianti, Matteo Fornai
Publikováno v:
British Journal of Pharmacology. 151:1246-1253
Background and purpose: Cholecystokinin is known to exert stimulant actions on intestinal motility via activation of type 1 cholecystokinin receptors (CCK1). However, the role played by cholecystokinin 2 (CCK2) receptors in the regulation of gut moti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::908588730cc4b81e7fe50a8ba89aac77
https://doi.org/10.1038/sj.bjp.0707339
https://doi.org/10.1038/sj.bjp.0707339